INO-4212: Phase I data

An open-label, U.S. Phase I trial in 75 healthy volunteers showed that INO-4212 given either intradermally or intramuscularly followed by electroporation was well tolerated. Of 69

Read the full 264 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE